The INKEY List: The British Indie Skincare Brand Closing Out The Vertical
Colette Laxton and Mark Curry met at Boots. Years later he messaged her on LinkedIn the day after she went freelance: 'I've got a business idea.' Eight years on, The INKEY List is the British indie skincare story closing this vertical. A celebration.
Across the past eleven brands of this magazine's skincare vertical, a pattern has been hard to miss. The Ordinary is owned by Estée Lauder. Drunk Elephant is owned by Shiseido. Tatcha is owned by Unilever. Paula's Choice is owned by Unilever. COSRX is owned by Amorepacific. rhode is owned by e.l.f. Beauty. Beauty of Joseon is a flagship subsidiary of Goodai Global. Cetaphil belongs to Galderma. Eucerin belongs to Beiersdorf. Augustinus Bader is independently held but at a luxury price tier most readers will not be shopping. Glow Recipe is one of the few exceptions: still independent, still founder-co-CEO-led.
Of the eleven brands we have reviewed, only two remain genuinely independent and founder-led at meaningful scale.
The brand that closes this skincare vertical is the third. It is also the British one. It is The INKEY List, co-founded by Colette Laxton and Mark Curry in 2018, headquartered in London, still independently owned, still founder-led, eight years after launch.
This is not a verdict piece. There is no list of alternatives. There is no "what to skip" section. This is a celebration of the British indie skincare brand we have been quietly recommending across every alternatives piece in this vertical, from The Ordinary onwards, and the brand we believe most deserves the editorial spotlight as the skincare vertical closes.
Colette Laxton and Mark Curry first met as colleagues at Boots UK, the British high-street pharmacy chain. Laxton was building a career across marketing, brand communications, and product development in beauty. Curry had a different background entirely, and this is the part most people miss when they tell the story. He was a microbiologist-virologist by training with a brief intervening career as a school teacher before joining the beauty industry.
They worked together at Boots, then went separate ways. Laxton continued in marketing leadership roles. Curry moved into product development with increasing responsibility for ingredient-led formulation thinking.
The story of The INKEY List begins with a single LinkedIn message.
The day after Laxton left her position to go freelance, the literal day after, Mark Curry messaged her on LinkedIn. The message, by Laxton's own retelling, was direct: "I heard good things about you when you were at Boots. Do you want to meet for a coffee? I've got a business idea."
The business idea, when Curry explained it over the coffee that followed, was this. The cosmetics industry had built itself, over decades, on opacity: branded marketing language, mysterious sub-categories, ingredient names buried at the bottom of packaging in 6pt type, ungrounded efficacy claims wrapped in luxury packaging at premium prices. The Ordinary had recently begun proving (since 2016) that consumers were willing to buy ingredient-led products at low prices in plain packaging if the marketing logic was honest. Curry believed there was room for a UK-rooted brand that took the same philosophy further: transparent, science-led, accessible, beautifully designed enough to feel cared for, but stripped of the cosmetics-counter mystique.
The brand name was The INKEY List, a play on "INCI list", the regulatory acronym for International Nomenclature of Cosmetic Ingredients, the standard format for ingredient labelling on cosmetic products globally. The reference is half clever pun, half mission statement. Read the ingredients. Know what is on your face.
Laxton agreed to co-found.
The Launch That Sold Out In Four Weeks
The INKEY List launched in September 2018 with a starting range of 15 products. The launch list was deliberately tight: niacinamide, hyaluronic acid, retinol, salicylic acid, alpha hydroxy acid, vitamin C, peptides, ceramides, squalane, panthenol, kaolin, caffeine. Twelve actives, fifteen products, plain white packaging with the active name in bold black text. Pricing started at £5.99 and topped out around £14.99.
The brand was founder-funded with private backing. The product manufacturing was small-batch. The launch stock was planned to last six months.
The day of launch, Cult Beauty, at the time the dominant UK independent online beauty retailer, placed an order for all of The INKEY List's stock on day one. Within four weeks, every product was sold out. Six months of planned inventory had cleared in twenty-eight days.
In October 2018, the founders met with Sephora.
The Sephora partnership that followed remains one of the fastest international beauty rollouts in recent history. Within twelve months of the September 2018 launch, The INKEY List was stocked in approximately 30 countries. By 2024, that figure was 32 countries, with the brand operating across Sephora EU, Sephora US, Sephora Asia, and Boots UK. In 2025, the brand launched into Ulta Beauty in the United States. By Curry and Laxton's own accounting, it outperformed their internal expectations.
Through all of it, the brand has remained independently owned.
There has been no Estée Lauder acquisition like The Ordinary. No L'Oréal sale like CeraVe. No Unilever takeover like Paula's Choice. No Shiseido buyout like Drunk Elephant. No e.l.f. Beauty deal like rhode. Mark Curry remains CEO. Colette Laxton remains co-founder and chief brand officer. The corporate structure that existed at launch in 2018 is essentially the corporate structure that exists today.
Why The Brand Works
The INKEY List works for a few specific reasons that we think are worth naming explicitly.
1. The pricing is honest. Most products are £8 to £15. The Niacinamide Serum is around £8. The Hyaluronic Acid Serum is around £8. The Retinol Serum is around £10-£15. The Salicylic Acid products are in the same band. There is no luxury tier. There is no premium-positioned line stretching toward £50 to capture margin. The brand has not crept upward in price in the way that post-acquisition Paula's Choice or Drunk Elephant have. This is the positioning that has stayed honest the longest.
2. The packaging is plain on purpose. White tubes, black text, ingredient name in bold, function in smaller text below. The aesthetic is closer to laboratory than to luxury. This is a deliberate inheritance from the brand's founding philosophy. The packaging cost is low, which keeps the price low, which keeps the product accessible. The aesthetic is functional rather than aspirational. The brand looks like what it is.
3. The ingredient transparency is real. Active concentrations are published on packaging where they are meaningful (10% Niacinamide, 1% Retinol, 2% Salicylic Acid, 6% Glycolic Acid). The product page on the brand's own site for each formula includes the full INCI list, an explanation of the active mechanism, and recommended layering protocols with other actives. This level of disclosure is rarer than it should be. The brand has continued to operate at this transparency level even as the range has grown.
4. The retail relationship with Sephora is structural rather than transactional. Sephora's EU and US partnerships have been The INKEY List's commercial spine since 2019. The brand is not a flash-in-the-pan TikTok product line. It is not an Instagram-only DTC. It is a brick-and-mortar-anchored ingredient skincare brand with a stable retail relationship across multiple continents. This structural retail presence is what has allowed the brand to scale without selling.
5. The founders are still the founders. Mark Curry is CEO. Colette Laxton is chief brand officer. They appear on podcasts together, write content together, run the company together, and have been open about the strategic and operational decisions that have kept the brand independent through a period when most of their peer competitors have sold. The founder-led nature is not a marketing claim. It is the operational reality.
The Heroes
For shoppers who have not bought from The INKEY List, the place to start is small. The hero products that have sustained the brand commercially are:
- Niacinamide Serum (around £8): the brand's bestseller. 10% niacinamide concentration in a lightweight, fragrance-free, well-formulated carrier. For most users, this product alone justifies the brand's existence. Effective for redness, oil control, gentle brightening, and as a daily morning serum. - Hyaluronic Acid Serum (around £8): multi-weight hyaluronic acid blend for layered hydration. The cosmetic finish is light, the absorption is fast, and the product layers well under SPF and moisturiser. - Retinol Serum (around £10-£15): entry-tier retinol product, well-formulated for users new to retinoids. Lower concentration than the Paula's Choice Clinical Retinal at £63, accessible enough for daily-tolerated use, and substantially cheaper. - Salicylic Acid Cleanser / 2% Salicylic Acid products: direct UK indie equivalent to Paula's Choice's iconic 2% BHA Liquid at a fraction of the price. - PHA Toner: a gentler chemical exfoliation alternative for sensitive skin. - Caffeine Eye Serum (around £10): competent depuffing and brightening eye treatment at less than a quarter of the price of premium-tier eye serums. - Hyram by Selfless (the brand's collaboration with skincare influencer Hyram Yarbro): the brand's first influencer collaboration line, launched into a sustainability-positioned format.
A complete starter routine of three or four INKEY products lands at roughly £25 to £45. By any measure, this is the most accessible serious-ingredient routine available in the UK in 2026.
The Wider Context
In 2025, The INKEY List had to raise prices in response to the tariffs introduced by the Trump administration in the United States. This was the first meaningful upward price movement in the brand's history. The founders were transparent about it in interviews: they explained the cost pressure, the manufacturing shifts they had attempted in response, and the limits of how much margin compression they could absorb before passing some increase to consumers. This level of honesty about pricing is also unusual. Most brands raise prices quietly and let the market notice.
The brand also entered physical retail with its first pop-up shop in 2025-2026, a meaningful step for a brand that had until then been almost entirely retail-counter at Sephora and Boots, with no standalone shopfront.
The 2026 strategic focus, by Curry's own account in recent industry interviews, is on continuing to win UK market share during a financially difficult period for British consumers, while building further on the Ulta Beauty US launch momentum.
These are the kinds of strategic priorities a founder-led independent brand has the freedom to pursue. Most of the post-acquisition brands we have reviewed in this vertical are operating against the strategic priorities of their corporate parents. The INKEY List is operating against its own.
The Wider Editorial Point
There is a reason this magazine has spent eleven verdict pieces and eleven alternatives pieces working through the skincare vertical. The British shopper in 2026 is buying skincare in a market that is substantially more concentrated than it appears on a Sephora UK shelf. Five conglomerates own the majority of the visible mainstream brands. Most of the founder stories on Sephora UK shelves are now historical, attached to brands whose corporate ownership has changed somewhere between two and ten years ago.
This does not make those brands bad. Many of the products are still excellent. The Dewy Skin Cream is still cult. The Ordinary Niacinamide is still a £5 staple. The Paula's Choice 2% BHA Liquid still earns its 1.25 million annual units.
It does mean that if you specifically want to support a still-independent founder-led skincare brand at a meaningful scale, the options on Sephora UK shelves are narrower than the marketing suggests. The INKEY List is, in 2026, the most prominent of those options at the accessibility tier. Pestle & Mortar holds that position at the premium tier (Irish, founder-led, family heritage). Aurelia is founder-led at the premium tier with a Health & Happiness Group ownership note. UpCircle holds it at the sustainability angle. Pixi holds it at the heritage UK glow tier. Naked Sundays holds it for SPF.
The cluster of UK and Irish indie brands we have referenced across every alternatives piece in this vertical is not random. Each of them was chosen because they remain genuinely founder-led and accessible to British shoppers in 2026. The INKEY List is the one that maps most directly onto the largest number of post-acquisition mainstream brands as a credible substitute. It is also the one with the richest founding story and the longest sustained track record at this scale.
The Honest Pitch
Most of the brands in this vertical have been reviewed honestly: what works, what is overpriced, what to skip, what corporate context matters. The INKEY List does not need that treatment. There is nothing to skip. There is no Unilever or Estée Lauder or Shiseido in the corporate parent column. The pricing is the pricing it has been since 2018.
If you have read all twelve pieces in this skincare vertical and you are looking for a single brand to start with that meets every criterion this magazine values (ingredient transparency, accessible pricing, genuine founder leadership, British provenance, retail availability), start with The INKEY List.
Buy the Niacinamide Serum. Buy the Hyaluronic Acid. Buy the Retinol. Spend £25 to £45 on three products. Build the rest of your routine over time.
That is the closing recommendation of this skincare vertical, and the British indie spotlight that closes it.
For Colette Laxton and Mark Curry, and for everyone who has watched a beauty brand stay genuinely independent through eight years of acquisition pressure, that is also our quiet thanks.
